Incentive Plans for Sales Representatives Sample Clauses

Incentive Plans for Sales Representatives. Each Party shall establish and implement a target bonus or sales incentive program whereunder such Party's Sales Representatives are compensated for their efforts with respect to Licensed Product in the Co-Promotion Territory in a manner consistent with the principles set forth in Sections 2.9 and 5.1 and with such Party's other programs for a similar nature product (and taking into consideration the commercial life cycle of the Licensed Product). All such programs shall be in compliance with all applicable laws, rules and regulations. Commencing at least six (6) months prior to filing of an NDA, and on an annual basis thereafter, the Parties shall exchange sufficient details on the target compensation, bonus structure, and benefits expected to be provided to their respective Sales Representatives with respect to the Licensed Product promoted by such individuals. In the event that either Party is concerned that such target bonus incentives for the Licensed Product are not reasonably comparable, then the JCC will discuss the issue at its next meeting in a good faith attempt to help resolve any such issues. Subject to the foregoing each Party shall retain final control over all decisions relating to compensation and bonus incentives for its Sales Representatives. Each Party will utilize data provided by IMS International (or another recognized service provider's data reasonably acceptable to the other Party) to determine the actual performance of its Sales Representatives for purposes of establishing compensation and bonuses.
Sample 1
AutoNDA by SimpleDocs
Incentive Plans for Sales Representatives. Each Party shall establish and implement a target bonus or sales incentive program whereunder such Party’s Sales Representatives are compensated for their efforts with respect to Products in a manner consistent with the principles set forth in Section 2.12 and with such Party’s other programs for similar products (and taking into consideration the commercial life cycles of the Products) and, to the extent reasonably practicable and subject to the remainder of this Section 4.15, consistent with the sales incentive programs for the other Party’s Sales Representatives. All such programs shall be in compliance with all Applicable Law. Each Party shall structure its incentive compensation programs for its Sales Representatives Detailing the Initial Product in the United States so that [*] (the “Reevaluation Date”). During the planning process for the Year following the Reevaluation Date, the Parties will, based on prevailing market conditions and Product performance, mutually agree upon the relative Weighting (or such other metric) of the Initial Product in relation to other products in each Party’s portfolio. “Weighting” means the average level of incentive compensation potential a product is given within a Sales Representative’s product portfolio on an annualized basis reasonably designed in a manner consistent with incentives provided for the applicable Party’s other products to incentivize Sales Representatives to promote the applicable product. [*] either Party shall have the right to have a Third Party consultant review the bonus and sales incentive programs implemented by the other Party for its Sales Representatives for compliance with the foregoing and to make recommendations to improve the alignment of such programs (with the foregoing and ensure that each Party’s Sales Representatives are appropriately incentivized); provided, that such consultant does not disclose to such Party the types or levels of bonuses or sales incentives applicable to the other Party’s Sales Representatives; and at the request of such Party the applicable ROC will discuss the issue at its next meeting in a good faith attempt to help resolve any such issues. Each Party shall retain final decision making authority over all decisions relating to compensation and bonus incentives for its Sales Representatives. Each Party shall utilize data provided by IMS International (or another recognized service provider reasonably acceptable to the other Party) to determine the actual perfor...
Sample 1
Incentive Plans for Sales Representatives. Each Party shall establish and implement a target bonus or sales incentive program whereunder such Party’s Sales Representatives are compensated for their efforts with respect to the Co-Promotion Products in the United States in a manner consistent with the principles set forth in Section 2.9 and with such Party’s other programs for a similar nature product (and taking into consideration the commercial life cycle of each Product). In any event, all such programs shall be in compliance with all Applicable Law. In the event that either Party is concerned that such target bonus incentives for a Co-Promotion Product are not reasonably comparable to one another in the United States, then such Party shall have the right to have a Third Party consultant, reasonably acceptable to the audited Party, review the bonus and sales incentive programs implemented by the other Party for its Sales Representatives and make recommendations to improve the alignment of such programs so that each Party’s Sales Representatives are appropriately incentivized; provided that such consultant does not disclose to such auditing Party the types or levels of bonuses or sales incentives applicable to the audited Party’s Sales Representatives; and, at the request of such Party, the JCC will discuss the issue at its next meeting in a good faith attempt to help resolve any such issues. Each Party shall retain final control over all decisions relating to compensation and bonus incentives for its Sales Representatives. Each Party shall utilize data provided by IMS International (or another recognized service provider reasonably acceptable to the other Party) to determine the actual performance of its Sales Representatives for purposes of establishing compensation and bonuses.
Sample 1
Incentive Plans for Sales Representatives. MJ and BMKK shall each establish and implement a target bonus or sales incentive program under which a Party’s Sales Representatives are compensated for their efforts with respect to Final Product in Japan with such Party’s other programs for a similar nature product in Japan (and taking into consideration the commercial life cycle of Final Product in Japan). In any event, all such programs shall be in compliance with all Applicable Law. MJ and BMKK shall use good faith efforts to align their target bonus or sales incentive programs to the extent reasonably practicable under the circumstances or otherwise ensure that their respective Sales Representatives are appropriately incentivized (but shall not disclose to one another base salaries or benefits payable to its Sales Representatives or any other compensation-related information other than the target bonus or sales incentive programs); provided however, that each Party shall retain final control over all decisions relating to compensation and bonus incentives for its Sales Representatives. Each Party shall utilize data provided by IMS International (or another recognized service provider reasonably acceptable to the other Party) to determine the actual performance of its Sales Representatives for purposes of establishing compensation and bonuses.
Sample 1
Incentive Plans for Sales Representatives. Each Party shall establish and implement a target bonus or sales incentive program whereunder such Party’s Sales Representatives in the United States are compensated for their actual performance results with respect to Product in a manner consistent with such Party’s other programs. All such programs shall be in compliance with all Applicable Laws. For clarity, the costs of such incentive programs shall not be included in Allowable Expenses hereunder.
Sample 1

Related to Incentive Plans for Sales Representatives

  • Sales Representatives Schedule 3.18.(c) contains a list of all sales representatives of Company, together with true, correct and complete copies of all sales representative contracts and policy statements, and a description of all substantial modifications or exceptions.

  • Sales Force During the term of this Agreement, Licensee shall maintain a non-exclusive sales force suitable to carry out the purpose of this Agreement.

  • Management Team Subject to any approval or consulting rights of the --------------- Joint Operations Committee, Manager shall engage or designate one or more individuals experienced in dental group management and direction, including, but not limited to, an administrator, who will be responsible for the overall administration of the Practice including day-to-day operations and strategic development activities.

  • Additional Directors Notwithstanding Articles 13.1 and 13.2, between annual general meetings or unanimous resolutions contemplated by Article 10.2, the directors may appoint one or more additional directors, but the number of additional directors appointed under this Article 14.8 must not at any time exceed:

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Medical Director (a) The HMO must have a qualified individual to serve as the Medical Director for its HHSC HMO Program(s). The Medical Director must be currently licensed in Texas under the Texas Medical Board as an M.D. or D.O. with no restrictions or other licensure limitations. The Medical Director must comply with the requirements of 28 T.A.C. §11.1606 and all applicable federal and state statutes and regulations.

  • Initial Directors The names and addresses of the initial Directors, to hold office from and after the date of this Agreement until their removal pursuant to this Agreement or until their respective successors are elected and qualified pursuant to this Agreement, are as set forth in Schedule 2.

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Joint Manufacturing Committee A joint manufacturing committee (the “Joint Manufacturing Committee” or “JMC”) will be established pursuant to the Supply Agreement. The roles and responsibilities of the JMC shall be as specified in the Supply Agreement.

  • Other Sales-Related Expenses Expenses of distributing the Portfolio's shares and the Contracts will be paid by Contracts Distributor and other parties, as they shall determine by separate agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.